InnovAge Holding Corp. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
InnovAge Holding Corp. (INNV) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 1.47 million shares for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-08.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-05-08
- InnovAge Holding Corp. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 1.47M shares, a 561.78% increase year-over-year.
- InnovAge Holding Corp. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-12-31 was 258.77K shares, a 44.99% decline year-over-year.
- InnovAge Holding Corp. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 258.77K shares, a 151.27% increase year-over-year.
- InnovAge Holding Corp. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 222.47K shares, a 91.42% increase year-over-year.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month |
|---|---|---|---|
| 2026-03-31 | 1.47M shares 10-Q · filed 2026-05-08 | 1.69M shares 10-Q · filed 2026-05-08 | |
| 2025-12-31 | 258.77K shares 10-Q · filed 2026-02-03 | 239.31K shares 10-Q · filed 2026-02-03 | |
| 2025-09-30 | 258.77K shares 10-Q · filed 2025-11-04 | ||
| 2025-03-31 | 222.47K shares 10-Q · filed 2026-05-08 | 389.53K shares 10-Q · filed 2026-05-08 | |
| 2024-12-31 | 470.42K shares 10-Q · filed 2026-02-03 | 398.77K shares 10-Q · filed 2026-02-03 | |
| 2024-09-30 | 102.98K shares 10-Q · filed 2025-11-04 | ||
| 2024-03-31 | 116.22K shares 10-Q · filed 2025-05-06 | 137.63K shares 10-Q · filed 2025-05-06 | |
| 2023-12-31 | 391.60K shares 10-Q · filed 2025-02-04 | 377.02K shares 10-Q · filed 2025-02-04 | |
| 2023-09-30 | 348.09K shares 10-Q · filed 2024-11-05 | ||
| 2023-03-31 | 659.76K shares 10-Q · filed 2024-05-07 | 37.90K shares 10-Q · filed 2024-05-07 | |
| 2022-12-31 | 424.32K shares 10-Q · filed 2024-02-06 | 14.08K shares 10-Q · filed 2024-02-06 | |
| 2022-09-30 | 0.00 shares 10-Q · filed 2022-11-08 | ||
| 2022-03-31 | 0.00 shares 10-Q · filed 2023-05-09 | 0.00 shares 10-Q · filed 2023-05-09 | |
| 2021-12-31 | 0.00 shares 10-Q · filed 2023-02-07 | 0.00 shares 10-Q · filed 2023-02-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |